MRK
$MRK
Merck & Co., Inc.
Global pharmaceutical leader known for Keytruda cancer immunotherapy and vaccines.
Healthcare$113.41
-0.04 (-0.04%)
Day Range$112.56 - $113.90
Prev Close$113.45
Analyst Rating
Strong Buy
25 Buy / 10 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
MRK: Defensive Pharma with Growth & Income
Merck ($MRK) combines a strong oncology franchise, high ROE, and a durable dividend with a favorable analyst consensus. Near-term catalysts and attractive valuation create upside, though policy and patent risks merit close monitoring.
Apr 6, 2026